Search

Your search keyword '"Murugesan, N."' showing total 228 results

Search Constraints

Start Over You searched for: Author "Murugesan, N." Remove constraint Author: "Murugesan, N."
228 results on '"Murugesan, N."'

Search Results

201. Brain regional angiogenic potential at the neurovascular unit during normal aging.

202. Rapid expression profiling of brain microvascular endothelial cells by immuno-laser capture microdissection coupled to TaqMan(®) low density array.

203. Characterization of a novel and selective CB1 antagonist as a radioligand for receptor occupancy studies.

204. The study of mitral valve annular dimension in relation to the body surface area in the Indian population.

205. Probing the CNS microvascular endothelium by immune-guided laser-capture microdissection coupled to quantitative RT-PCR.

206. Analysis of mouse brain microvascular endothelium using laser capture microdissection coupled with proteomics.

207. Endothelial cell heterogeneity of blood-brain barrier gene expression along the cerebral microvasculature.

208. Astrocyte- and endothelial-targeted CCL2 conditional knockout mice: critical tools for studying the pathogenesis of neuroinflammation.

209. Validation of immuno-laser capture microdissection coupled with quantitative RT-PCR to probe blood-brain barrier gene expression in situ.

210. Synthesis and in vivo evaluation of novel PET radioligands for imaging the endothelin-A receptor.

211. Population based study of quality of diabetes care in southern India.

212. Analysis of mouse brain microvascular endothelium using immuno-laser capture microdissection coupled to a hybrid linear ion trap with Fourier transform-mass spectrometry proteomics platform.

213. High prevalence of diabetes and cardiovascular risk factors associated with urbanization in India.

214. Design and SAR of selective T-type calcium channel antagonists containing a biaryl sulfonamide core.

215. High prevalence of cardiometabolic risk factors among young physicians in India.

216. Insulin resistance and clustering of cardiometabolic risk factors in urban teenagers in southern India.

217. Reduction of site-specific CYP3A-mediated metabolism for dual angiotensin and endothelin receptor antagonists in various in vitro systems and in cynomolgus monkeys.

219. Tryptamine and homotryptamine-based sulfonamides as potent and selective inhibitors of 15-lipoxygenase.

220. Novel dual action AT1 and ETA receptor antagonists reduce blood pressure in experimental hypertension.

221. Community mobilisation for leprosy elimination.

223. Discovery of 4'-[(imidazol-1-yl)methyl]biphenyl-2-sulfonamides as dual endothelin/angiotensin II receptor antagonists.

224. Biphenylsulfonamide endothelin antagonists: structure-activity relationships of a series of mono- and disubstituted analogues and pharmacology of the orally active endothelin antagonist 2'-amino-N- (3,4-dimethyl-5-isoxazolyl)-4'-(2-methylpropyl)[1, 1'-biphenyl]-2-sulfonamide (BMS-187308).

225. The discovery of sulfonamide endothelin antagonists and the development of the orally active ETA antagonist 5-(dimethylamino)-N-(3,4-dimethyl-5-isoxazolyl)-1-naphthalenesulf onamide.

227. Analysis of products formed during bleomycin-mediated DNA degradation.

228. Chemistry of the alkali-labile lesion formed from iron(II) bleomycin and d(CGCTTTAAAGCG).

Catalog

Books, media, physical & digital resources